NutriBand (NTRB) Common Equity (2016 - 2026)
NutriBand's (NTRB) quarterly Common Equity came in at $6.7 million in Q1 2026, down 10.58% year-on-year from $7.5 million in Q1 2025, and down 11.52% quarter-over-quarter from $7.5 million in Q4 2025.
NutriBand (NTRB) Common Equity (2016 - 2026) Analysis & Trends
NutriBand has disclosed Common Equity across 11 years of filings, most recently posting $6.7 million for Q1 2026.
- Common Equity for Q1 2026 came in at $6.7 million, down 10.58% year-over-year; the trailing twelve-month figure through Jan 2026 was $6.7 million (down 10.58% YoY), and the FY2026 annual result was $6.7 million, down 10.58% from the prior year.
- Common Equity came in at $6.7 million for Q1 2026 at NutriBand, down from $7.5 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $13.4 million in Q2 2024 to a low of $5.1 million in Q2 2025.
- The 5-year median for Common Equity is $8.5 million (2025), against an average of $8.9 million.
- Across the five-year window, Common Equity jumped 96.66% in 2024 and slumped 61.81% in 2025, its largest moves.
- NutriBand's Common Equity stood at $9.7 million in 2022, then tumbled by 41.31% to $5.7 million in 2023, then surged by 96.66% to $11.2 million in 2024, then slumped by 32.79% to $7.5 million in 2025, then dropped by 11.52% to $6.7 million in 2026.
- The last three Common Equity figures came in at $6.7 million (Q1 2026), $7.5 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 13.21 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 6.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 6.68 Mn |
| Oct 31, 2025 | 7.55 Mn |
| Jul 31, 2025 | 8.49 Mn |
| Apr 30, 2025 | 5.10 Mn |
| Jan 31, 2025 | 7.47 Mn |
| Oct 31, 2024 | 11.23 Mn |
| Jul 31, 2024 | 12.46 Mn |
| Apr 30, 2024 | 13.36 Mn |
| Jan 31, 2024 | 6.44 Mn |
| Oct 31, 2023 | 5.71 Mn |
| Jul 31, 2023 | 6.89 Mn |
| Apr 30, 2023 | 7.72 Mn |
| Jan 31, 2023 | 8.57 Mn |
| Oct 31, 2022 | 9.73 Mn |
| Jul 31, 2022 | 10.40 Mn |
| Apr 30, 2022 | 11.08 Mn |
| Jan 31, 2022 | 11.86 Mn |
| Oct 31, 2021 | 14.32 Mn |
| Jul 31, 2021 | 7.32 Mn |
| Apr 30, 2021 | 7.84 Mn |